Insider transactions

EDGAR

Aveanna Healthcare Holdings Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
71 transactions, 80,870,340 shares
Sum of shares × price per share: 781,631,742.8081

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 95

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-01 Filed 2026-10-05Stewart Deborah Officer: SVP, Chief Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, par value $0.01 per share
Acquired (A)75,0000—377,844Direct (D) No
F1, F2
  • F1 Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.
  • F2 Includes 1,037 shares acquired under the Registrant's Employee Stock Purchase Plan (the ESPP) in June 2026.
Open filing 0001193125-26-414322 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-24J.H. Whitney Equity Partners VII, LLC 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)2,250,00011.50
25,875,000

Derived: shares × price per share. Exact value 25875000.00.

12,315,892Indirect (I) By PSA Healthcare Investment Holding LLCNo
F5, F1
  • F5 On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363869 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-24WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)2,250,00011.50
25,875,000

Derived: shares × price per share. Exact value 25875000.00.

12,315,892Indirect (I) By PSA Healthcare Investment Holding LLCNo
F10, F1
  • F10 On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363868 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-24VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)2,250,00011.50
25,875,000

Derived: shares × price per share. Exact value 25875000.00.

12,315,892Indirect (I) By PSA Healthcare Investment Holding LLCNo
F10, F1
  • F10 On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363860 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24Reisz Edwin C. Officer: Chief Administrative Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)50,00011.5
575,000

Derived: shares × price per share. Exact value 575000.0.

1,397,897Direct (D) No
F1, F2
  • F1 Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.
  • F2 Includes 840 shares acquired under the Registrant's Employee Stock Purchase Plan (the ESPP) in June 2026.
Open filing 0001193125-26-363658 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24J.H. Whitney Equity Partners VII, LLC 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)10,112,12511.50
116,289,437.5

Derived: shares × price per share. Exact value 116289437.50.

0Indirect (I) By J.H. Whitney VII, L.P.No
F2, F1
  • F2 On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363869 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24J.H. Whitney Equity Partners VII, LLC 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)957,91811.50
11,016,057

Derived: shares × price per share. Exact value 11016057.00.

14,565,892Indirect (I) By PSA Healthcare Investment Holding LLCNo
F3, F1
  • F3 On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363869 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24J.H. Whitney Equity Partners VII, LLC 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)1,426,03411.50
16,399,391

Derived: shares × price per share. Exact value 16399391.00.

0Indirect (I) By PSA Iliad Holdings LLCNo
F4, F1
  • F4 On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363869 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24Windley Rodney D Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)180,00011.5
2,070,000

Derived: shares × price per share. Exact value 2070000.0.

2,078,017Direct (D) No
F1
  • F1 Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.
Open filing 0001193125-26-363665 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)10,112,12511.50
116,289,437.5

Derived: shares × price per share. Exact value 116289437.50.

0Indirect (I) By J.H. Whitney VII, L.P.No
F5, F1
  • F5 On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363868 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)957,91811.50
11,016,057

Derived: shares × price per share. Exact value 11016057.00.

14,565,892Indirect (I) By PSA Healthcare Investment Holding LLCNo
F6, F1
  • F6 On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363868 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)1,813,79511.50
20,858,642.5

Derived: shares × price per share. Exact value 20858642.50.

0Indirect (I) By JHW Iliad Holdings, LLCNo
F7, F2
  • F7 On August 20, 2026, JHW Iliad Holdings, LLC sold 1,813,795 Shares pursuant to an underwritten secondary offering.
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363868 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)1,426,03411.50
16,399,391

Derived: shares × price per share. Exact value 16399391.00.

0Indirect (I) By PSA Iliad Holdings LLCNo
F8, F1
  • F8 On August 20, 2026, JHW Iliad Holdings II, LLC sold 190,130 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363868 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)190,13011.50
2,186,495

Derived: shares × price per share. Exact value 2186495.00.

0Indirect (I) By JHW Iliad Holdings II, LLCNo
F9, F2, F3
  • F9 On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering.
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • F3 J.H. Whitney Capital Partners, LLC (Capital Partners) is the sole member of J.H. Whitney VII Management Co., LLC (Management Co. VII), which is the managing member of JHW Iliad Holdings II LLC (JHW Iliad II, and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the Stockholder Entities). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363868 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24Shaner Jeff Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)90,00011.5
1,035,000

Derived: shares × price per share. Exact value 1035000.0.

2,561,972Direct (D) No
F1, F2
  • F1 Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.
  • F2 Includes 1,080 shares acquired under the Registrant's Employee Stock Purchase Plan (the ESPP) in June 2026.
Open filing 0001193125-26-363661 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)10,112,12511.50
116,289,437.5

Derived: shares × price per share. Exact value 116289437.50.

0Indirect (I) By J.H. Whitney VII, L.P.No
F5, F1
  • F5 On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363860 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)957,91811.50
11,016,057

Derived: shares × price per share. Exact value 11016057.00.

14,565,892Indirect (I) By PSA Healthcare Investment Holding LLCNo
F6, F1
  • F6 On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363860 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)1,813,79511.50
20,858,642.5

Derived: shares × price per share. Exact value 20858642.50.

0Indirect (I) By JHW Iliad Holdings, LLCNo
F7, F2
  • F7 On August 20, 2026, JHW Iliad Holdings, LLC sold 1,813,795 Shares pursuant to an underwritten secondary offering.
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363860 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)1,426,03411.50
16,399,391

Derived: shares × price per share. Exact value 16399391.00.

0Indirect (I) By PSA Iliad Holdings LLCNo
F8, F1
  • F8 On August 20, 2026, JHW Iliad Holdings II, LLC sold 190,130 Shares pursuant to an underwritten secondary offering.
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363860 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)190,13011.50
2,186,495

Derived: shares × price per share. Exact value 2186495.00.

0Indirect (I) By JHW Iliad Holdings II, LLCNo
F9, F2, F3
  • F9 On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering.
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • F3 J.H. Whitney Capital Partners, LLC (Capital Partners) is the sole member of J.H. Whitney VII Management Co., LLC (Management Co. VII), which is the managing member of JHW Iliad Holdings II LLC (JHW Iliad II, and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the Stockholder Entities). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-363860 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)2,419,0358.01
19,376,470.35

Derived: shares × price per share. Exact value 19376470.35.

10,112,123Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-293930 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)525,8448.01
4,212,010.44

Derived: shares × price per share. Exact value 4212010.44.

1,813,795Indirect (I) By JHW Iliad Holdings LLCNo
F2
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-293930 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)55,1218.01
441,519.21

Derived: shares × price per share. Exact value 441519.21.

190,130Indirect (I) By JHW Iliad Holdings II LLCNo
F2, F3
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • F3 J.H. Whitney Capital Partners, LLC (Capital Partners) is the sole member of J.H. Whitney VII Management Co., LLC (Management Co. VII), which is the managing member of JHW Iliad Holdings II LLC (JHW Iliad II, and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the Stockholder Entities). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-293930 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)2,419,0358.01
19,376,470.35

Derived: shares × price per share. Exact value 19376470.35.

10,112,123Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-293937 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)525,8448.01
4,212,010.44

Derived: shares × price per share. Exact value 4212010.44.

1,813,795Indirect (I) By JHW Iliad Holdings LLCNo
F2
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-293937 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)55,1218.01
441,519.21

Derived: shares × price per share. Exact value 441519.21.

190,130Indirect (I) By JHW Iliad Holdings II LLCNo
F2, F3
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • F3 J.H. Whitney Capital Partners, LLC (Capital Partners) is the sole member of J.H. Whitney VII Management Co., LLC (Management Co. VII), which is the managing member of JHW Iliad Holdings II LLC (JHW Iliad II, and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the Stockholder Entities). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-293937 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02J.H. Whitney Equity Partners VII, LLC 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)2,419,0358.01
19,376,470.35

Derived: shares × price per share. Exact value 19376470.35.

10,112,123Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-293921 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)919,3898.00
7,355,112

Derived: shares × price per share. Exact value 7355112.00.

12,531,158Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-284893 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)72,9638.00
583,704

Derived: shares × price per share. Exact value 583704.00.

2,339,639Indirect (I) By JHW Iliad Holdings LLCNo
F2
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-284893 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)7,6488.00
61,184

Derived: shares × price per share. Exact value 61184.00.

245,251Indirect (I) By JHW Iliad Holdings II LLCNo
F2, F3
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • F3 J.H. Whitney Capital Partners, LLC (Capital Partners) is the sole member of J.H. Whitney VII Management Co., LLC (Management Co. VII), which is the managing member of JHW Iliad Holdings II LLC (JHW Iliad II, and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the Stockholder Entities). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-284893 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26J.H. Whitney Equity Partners VII, LLC 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)919,3898.00
7,355,112

Derived: shares × price per share. Exact value 7355112.00.

12,531,158Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-284870 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)919,3898.00
7,355,112

Derived: shares × price per share. Exact value 7355112.00.

12,531,158Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-284855 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)72,9638.00
583,704

Derived: shares × price per share. Exact value 583704.00.

2,339,639Indirect (I) By JHW Iliad Holdings LLCNo
F2
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-284855 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-26VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)7,6488.00
61,184

Derived: shares × price per share. Exact value 61184.00.

245,251Indirect (I) By JHW Iliad Holdings II LLCNo
F2, F3
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • F3 J.H. Whitney Capital Partners, LLC (Capital Partners) is the sole member of J.H. Whitney VII Management Co., LLC (Management Co. VII), which is the managing member of JHW Iliad Holdings II LLC (JHW Iliad II, and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the Stockholder Entities). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-284855 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-05WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)5,842,2406.24
36,455,577.6

Derived: shares × price per share. Exact value 36455577.60.

13,450,547Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-258798 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-05WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)1,047,9136.24
6,538,977.12

Derived: shares × price per share. Exact value 6538977.12.

2,412,602Indirect (I) By JHW Iliad Holdings LLCNo
F2
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-258798 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-05WILLIAMS ROBERT M JR 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)109,8476.24
685,445.28

Derived: shares × price per share. Exact value 685445.28.

252,899Indirect (I) By JHW Iliad Holdings II LLCNo
F2, F3
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • F3 J.H. Whitney Capital Partners, LLC (Capital Partners) is the sole member of J.H. Whitney VII Management Co., LLC (Management Co. VII), which is the managing member of JHW Iliad Holdings II LLC (JHW Iliad II, and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the Stockholder Entities). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-258798 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-05J.H. Whitney Equity Partners VII, LLC 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)5,842,2406.24
36,455,577.6

Derived: shares × price per share. Exact value 36455577.60.

13,450,547Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings, and, collectively with JHW VII and PSA Healthcare, the Stockholder Entities). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-258790 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-05VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)5,842,2406.24
36,455,577.6

Derived: shares × price per share. Exact value 36455577.60.

13,450,547Indirect (I) By J.H. Whitney VII, L.P.No
F1
  • F1 J.H. Whitney Equity Partners VII, LLC (Equity Partners VII) is the general partner of J.H. Whitney VII, L.P. (JHW VII) and Whitney Strategic Partners VII, L.P. (Strategic Partners VII). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC (PSA Healthcare) and PSA Iliad Holdings LLC (PSA Iliad Holdings). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the Shares), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-258806 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-05VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)1,047,9136.24
6,538,977.12

Derived: shares × price per share. Exact value 6538977.12.

2,412,602Indirect (I) By JHW Iliad Holdings LLCNo
F2
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-258806 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-05VIGANO PAUL R 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value
Disposed (D)109,8476.24
685,445.28

Derived: shares × price per share. Exact value 685445.28.

252,899Indirect (I) By JHW Iliad Holdings II LLCNo
F2, F3
  • F2 Project Iliad Managing Member, LLC (Project Iliad) is the managing member of JHW Iliad Holdings LLC (JHW Iliad). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • F3 J.H. Whitney Capital Partners, LLC (Capital Partners) is the sole member of J.H. Whitney VII Management Co., LLC (Management Co. VII), which is the managing member of JHW Iliad Holdings II LLC (JHW Iliad II, and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the Stockholder Entities). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Open filing 0001193125-26-258806 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-21Cunningham Patrick A. Officer: Chief Compliance Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)125,0007.5883
948,537.5

Derived: shares × price per share. Exact value 948537.5000.

212,755Direct (D) No
F1
  • F1 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.50 to $7.69. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-235087 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-19Reisz Edwin C. Officer: Chief Administrative Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)60,7697.2082
438,035.1058

Derived: shares × price per share. Exact value 438035.1058.

1,447,057Direct (D) Yes
F1, F4
  • F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
  • F4 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-060051 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-19Stewart Deborah Officer: SVP, Chief Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)11,1817.2082
80,594.8842

Derived: shares × price per share. Exact value 80594.8842.

301,807Direct (D) Yes
F1, F4
  • F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
  • F4 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-060055 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-19Cunningham Patrick A. Officer: Chief Compliance Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)18,4367.2082
132,890.3752

Derived: shares × price per share. Exact value 132890.3752.

337,755Direct (D) Yes
F1, F4
  • F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
  • F4 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-060059 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-19Shaner Jeff Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)173,2257.2082
1,248,640.445

Derived: shares × price per share. Exact value 1248640.4450.

2,650,892Direct (D) Yes
F1, F4
  • F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
  • F4 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-060060 Read from the filing’s XML Dispute this row
2026-02-19 Filed 2026-02-19Buckhalter Matthew Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)13,5127.2082
97,397.1984

Derived: shares × price per share. Exact value 97397.1984.

529,243Direct (D) Yes
F1, F4
  • F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
  • F4 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-060058 Read from the filing’s XML Dispute this row
2026-02-18 Filed 2026-02-19Reisz Edwin C. Officer: Chief Administrative Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)59,2177.3829
437,193.1893

Derived: shares × price per share. Exact value 437193.1893.

1,507,826Direct (D) Yes
F1, F3
  • F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
  • F3 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-060051 Read from the filing’s XML Dispute this row
2026-02-18 Filed 2026-02-19Stewart Deborah Officer: SVP, Chief Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)10,8967.3829
80,444.0784

Derived: shares × price per share. Exact value 80444.0784.

312,988Direct (D) Yes
F1, F3
  • F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
  • F3 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-060055 Read from the filing’s XML Dispute this row
2026-02-18 Filed 2026-02-19Cunningham Patrick A. Officer: Chief Compliance Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)17,9657.3829
132,633.7985

Derived: shares × price per share. Exact value 132633.7985.

356,191Direct (D) Yes
F1, F3
  • F1 Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
  • F3 The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001193125-26-060059 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 269

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Bain Capital Investors LLC 81,600,880 SH1,012,666,921 dollarsUnchanged Prior quarter: 81,600,880Open filing 0001193125-26-462000 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager8,265,152 SH102,570,536 dollarsHigher by 855,099 Prior quarter: 7,410,053Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager7,798,485 SH96,779,201 dollarsHigher by 6,261,226 Prior quarter: 1,537,259Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Nut Tree Capital Management, LP 6,236,971 SH77,400,810 dollarsLower by 6,685,678 Prior quarter: 12,922,649Open filing 0001661655-26-000004 Filed 2026-11-16 Dispute this row
Ophir Asset Management Pty Ltd 4,920,248 SH61,060,278 dollarsLower by 179,752 Prior quarter: 5,100,000Open filing 0001844640-26-000009 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 4,904,264 SH60,861,916 dollarsHigher by 1,231,046 Prior quarter: 3,673,218Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager4,813,143 SH59,731,104 dollarsNot in the prior quarter’s filings read Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager3,916,998 SH48,609,945 dollarsHigher by 2,244,326 Prior quarter: 1,672,672Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row
BRAIDWELL LP 3,870,106 SH48,028,015 dollarsHigher by 805,000 Prior quarter: 3,065,106Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row
Hood River Capital Management LLC 3,548,994 SH44,043,016 dollarsNot in the prior quarter’s filings read Open filing 0001214659-26-014212 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager3,511,747 SH43,587,860 dollarsHigher by 1,254,063 Prior quarter: 2,257,684Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager3,038,724 SH37,710,565 dollarsHigher by 752,968 Prior quarter: 2,285,756Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Boston Partners Partly reported under another manager3,024,899 SH37,450,363 dollarsHigher by 153,920 Prior quarter: 2,870,979Open filing 0001386060-26-000054 Filed 2026-11-10 Dispute this row
MILLENNIUM MANAGEMENT LLC 2,874,000 SH35,666,340 dollarsNot in the prior quarter’s filings read Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager2,666,927 SH33,105,384 dollarsHigher by 603,190 Prior quarter: 2,063,737Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Qube Research Technologies Ltd 2,594,559 SH32,198,477 dollarsHigher by 1,938,830 Prior quarter: 655,729Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
Nuveen, LLC Partly reported under another manager2,370,329 SH29,415,782 dollarsHigher by 805,282 Prior quarter: 1,565,047Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Woodline Partners LP 2,370,087 SH29,412,780 dollarsHigher by 1,680,773 Prior quarter: 689,314Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager2,337,987 SH29,014,419 dollarsHigher by 386,347 Prior quarter: 1,951,640Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
TWO SIGMA INVESTMENTS, LP 2,180,979 SH27,065,949 dollarsHigher by 988,810 Prior quarter: 1,192,169Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager1,849,337 SH22,950,276 dollarsHigher by 575,303 Prior quarter: 1,274,034Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Driehaus Capital Management LLC 1,784,832 SH22,149,765 dollarsNot in the prior quarter’s filings read Open filing 0000938206-26-000066 Filed 2026-11-16 Dispute this row
ALGERT GLOBAL LLC Partly reported under another manager1,644,456 SH20,407,699 dollarsHigher by 33,709 Prior quarter: 1,610,747Open filing 0001275218-26-000018 Filed 2026-11-17 Dispute this row
FEDERATED HERMES, INC. Partly reported under another manager1,616,116 SH20,056,000 dollarsHigher by 852,131 Prior quarter: 763,985Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager1,583,956 SH20,278,767 dollarsHigher by 79,943 Prior quarter: 1,504,013Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 1,416,438 SH17,577,996 dollarsHigher by 22,939 Prior quarter: 1,393,499Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
FIRST TRUST ADVISORS LP 1,401,516 SH17,392,813 dollarsHigher by 735,090 Prior quarter: 666,426Open filing 0001445546-26-008622 Filed 2026-11-12 Dispute this row
EMERALD ADVISERS, LLC 1,398,173 SH17,351,327 dollarsLower by 244,233 Prior quarter: 1,642,406Open filing 0001104659-26-124249 Filed 2026-11-09 Dispute this row
OBERWEIS ASSET MANAGEMENT INC/ 1,254,735 SH15,571,261 dollarsNot in the prior quarter’s filings read Open filing 0001213900-26-120411 Filed 2026-11-16 Dispute this row
Parkman Healthcare Partners LLC 1,126,599 SH13,981,094 dollarsHigher by 412,148 Prior quarter: 714,451Open filing 0001420506-26-002809 Filed 2026-11-16 Dispute this row
J.H. Whitney Equity Partners VII, LLC 1,036,300 SH12,860,483 dollarsLower by 26,025,667 Prior quarter: 27,061,967Open filing 0001193125-26-455997 Filed 2026-11-12 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager1,015,533 SH12,602,764 dollarsHigher by 180,087 Prior quarter: 835,446Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager1,015,004 SH12,595,804 dollarsHigher by 97,175 Prior quarter: 917,829Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
Sio Capital Management, LLC 1,012,102 SH12,560,186 dollarsHigher by 643,066 Prior quarter: 369,036Open filing 0001214659-26-014302 Filed 2026-11-16 Dispute this row
Hillsdale Investment Management Inc. 1,009,060 SH12,522,435 dollarsLower by 670 Prior quarter: 1,009,730Open filing 0001193125-26-457091 Filed 2026-11-12 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 973,125 SH12,076,481 dollarsHigher by 358,387 Prior quarter: 614,738Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager971,685 SH12,058,612 dollarsHigher by 133,727 Prior quarter: 837,958Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager954,216 SH11,841,821 dollarsHigher by 138,100 Prior quarter: 816,116Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
RAYMOND JAMES FINANCIAL INC Partly reported under another manager883,536 SH10,964,684 dollarsLower by 278,106 Prior quarter: 1,161,642Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager855,068 SH10,611,393 dollarsHigher by 140,489 Prior quarter: 714,579Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Assenagon Asset Management S.A. 814,596 SH10,109,136 dollarsLower by 1,006,188 Prior quarter: 1,820,784Open filing 0001546007-26-000008 Filed 2026-10-15 Dispute this row
PANAGORA ASSET MANAGEMENT INC 813,772 SH10,098,911 dollarsHigher by 47,909 Prior quarter: 765,863Open filing 0000883677-26-000011 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 797,702 SH9,899,482 dollarsHigher by 262,998 Prior quarter: 534,704Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
First Eagle Investment Management, LLC 770,667 SH9,563,977 dollarsLower by 758,667 Prior quarter: 1,529,334Open filing 0001325447-26-000037 Filed 2026-11-10 Dispute this row
Point72 Asset Management, L.P. 764,175 SH9,483,412 dollarsLower by 1,039,276 Prior quarter: 1,803,451Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
Squarepoint Ops LLC Partly reported under another manager755,855 SH9,380,161 dollarsHigher by 121,955 Prior quarter: 633,900Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
Allianz Asset Management GmbH Partly reported under another manager742,270 SH9,211,571 dollarsHigher by 206,111 Prior quarter: 536,159Open filing 0001193125-26-463640 Filed 2026-11-16 Dispute this row
MACKENZIE FINANCIAL CORP 734,710 SH9,117,751 dollarsLower by 1,372,795 Prior quarter: 2,107,505Open filing 0001062993-26-005652 Filed 2026-11-02 Dispute this row
EMERALD MUTUAL FUND ADVISERS TRUST 681,850 SH8,461,759 dollarsLower by 285,258 Prior quarter: 967,108Open filing 0001104659-26-124247 Filed 2026-11-09 Dispute this row
CITIGROUP INC Partly reported under another manager666,996 SH8,277,420 dollarsHigher by 623,756 Prior quarter: 43,240Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Connor, Clark Lunn Investment Management Ltd. 919,627 SH
  • Sixth Street Partners Management Company, L.P. 614,738 SH
  • ADAGE CAPITAL PARTNERS GP, L.L.C. 223,802 SH
  • LITTLEJOHN CO LLC 215,505 SH
  • JACOBS LEVY EQUITY MANAGEMENT, INC 212,197 SH
  • Cinctive Capital Management LP 174,774 SH
  • WESBANCO BANK INC 77,000 SH
  • EntryPoint Capital, LLC 70,397 SH
  • Mitsubishi UFJ Trust Banking Corp 48,530 SH
  • MANGROVE PARTNERS IM, LLC 47,288 SH
  • Graham Capital Management, L.P. 46,525 SH
  • Aquatic Capital Management LLC 38,297 SH
  • Y-Intercept (Hong Kong) Ltd 30,956 SH
  • Lighthouse Investment Partners, LLC 25,600 SH
  • Jaffetilchin Investment Partners, LLC 23,800 SH
  • Jupiter Topco LLC 23,600 SH
  • Mach-1 Financial Group, LLC 17,453 SH
  • INTECH INVESTMENT MANAGEMENT LLC 16,214 SH
  • Olympiad Research LP 14,603 SH
  • PRELUDE CAPITAL MANAGEMENT, LLC 14,500 SH
  • PharVision Advisers, LLC 14,135 SH
  • MIRABELLA FINANCIAL SERVICES LLP 13,598 SH
  • IMC-Chicago, LLC 13,100 SH
  • Hamilton Wealth, LLC 13,000 SH
  • LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 11,848 SH
  • Freestone Grove Partners LP 8,484 SH
  • ISLAY CAPITAL MANAGEMENT, LLC 3,657 SH
  • Kilter Group LLC 2,607 SH
  • Integrated Wealth Concepts LLC 1,923 SH
  • Aster Capital Management (DIFC) Ltd 725 SH
  • Optiver Holding B.V. 360 SH
  • Wealth Enhancement Trust Services, Inc. 205 SH
  • Rockefeller Capital Management L.P. 24 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Nut Tree Capital Management, LP Common Stock, par value $0.01 per share2.96,236,971.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000905148-26-004948 Dispute this row
Nut Tree Capital Management GP, LLC Common Stock, par value $0.01 per share2.96,236,971.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000905148-26-004948 Dispute this row
Jared R. Nussbaum Common Stock, par value $0.01 per share2.96,236,971.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000905148-26-004948 Dispute this row
PSA Healthcare Investment Holding LLC Common Stock, $.01 Par Value0.000.0009/30/2026 Filed 2026-11-10SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-456006 Dispute this row
J.H. Whitney VII, L.P. Common Stock, $.01 Par Value0.481,036,300.0009/30/2026 Filed 2026-11-10SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-456006 Dispute this row
PSA Iliad Holdings LLC Common Stock, $.01 Par Value0.000.0009/30/2026 Filed 2026-11-10SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-456006 Dispute this row
JHW Iliad Holdings LLC Common Stock, $.01 Par Value0.000.0009/30/2026 Filed 2026-11-10SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-456006 Dispute this row
JHW Iliad Holdings II LLC Common Stock, $.01 Par Value0.000.0009/30/2026 Filed 2026-11-10SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-456006 Dispute this row
PSA Healthcare Investment Holding LLC Common Stock, $.01 Par Value7.1315,523,810.0006/30/2026 Filed 2026-08-03SCHEDULE 13G/AAmendment 5Open filing 0001193125-26-330725 Dispute this row
J.H. Whitney VII, L.P. Common Stock, $.01 Par Value4.6410,112,123.0006/30/2026 Filed 2026-08-03SCHEDULE 13G/AAmendment 5Open filing 0001193125-26-330725 Dispute this row
PSA Iliad Holdings LLC Common Stock, $.01 Par Value0.651,426,034.0006/30/2026 Filed 2026-08-03SCHEDULE 13G/AAmendment 5Open filing 0001193125-26-330725 Dispute this row
JHW Iliad Holdings LLC Common Stock, $.01 Par Value0.831,813,795.0006/30/2026 Filed 2026-08-03SCHEDULE 13G/AAmendment 5Open filing 0001193125-26-330725 Dispute this row
JHW Iliad Holdings II LLC Common Stock, $.01 Par Value0.09190,130.0006/30/2026 Filed 2026-08-03SCHEDULE 13G/AAmendment 5Open filing 0001193125-26-330725 Dispute this row
PSA Healthcare Investment Holding LLC Common Stock, $.01 Par Value7.4315,523,810.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-044998 Dispute this row
J.H. Whitney VII, L.P. Common Stock, $.01 Par Value9.2319,292,787.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-044998 Dispute this row
PSA Iliad Holdings LLC Common Stock, $.01 Par Value0.681,426,034.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-044998 Dispute this row
JHW Iliad Holdings LLC Common Stock, $.01 Par Value1.663,460,515.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-044998 Dispute this row
JHW Iliad Holdings II LLC Common Stock, $.01 Par Value0.17362,746.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-044998 Dispute this row
PSA Healthcare Investment Holding LLC Common Stock, $.01 Par Value7.4315,523,810.0009/30/2025 Filed 2025-11-10SCHEDULE 13G/AAmendment 3Open filing 0001193125-25-274411 Dispute this row
J.H. Whitney VII, L.P. Common Stock, $.01 Par Value13.8328,890,755.0009/30/2025 Filed 2025-11-10SCHEDULE 13G/AAmendment 3Open filing 0001193125-25-274411 Dispute this row
PSA Iliad Holdings LLC Common Stock, $.01 Par Value0.681,426,034.0009/30/2025 Filed 2025-11-10SCHEDULE 13G/AAmendment 3Open filing 0001193125-25-274411 Dispute this row
JHW Iliad Holdings LLC Common Stock, $.01 Par Value2.485,182,085.0009/30/2025 Filed 2025-11-10SCHEDULE 13G/AAmendment 3Open filing 0001193125-25-274411 Dispute this row
JHW Iliad Holdings II LLC Common Stock, $.01 Par Value0.26543,206.0009/30/2025 Filed 2025-11-10SCHEDULE 13G/AAmendment 3Open filing 0001193125-25-274411 Dispute this row
PSA Healthcare Investment Holdings LLC Common Stock, $.01 Par Value7.9915,588,583.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 2Open filing 0000950170-25-106484 Dispute this row
J.H. Whitney VII, L.P. Common Stock, $.01 Par Value14.8128,890,755.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 2Open filing 0000950170-25-106484 Dispute this row
PSA Iliad Holdings LLC Common Stock, $.01 Par Value0.741,443,143.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 2Open filing 0000950170-25-106484 Dispute this row
JHW Iliad Holdings LLC Common Stock, $.01 Par Value2.665,182,085.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 2Open filing 0000950170-25-106484 Dispute this row
JHW Iliad Holdings II LLC Common Stock, $.01 Par Value0.28543,206.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 2Open filing 0000950170-25-106484 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,686,536 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,154

Filings made before the SEC required XML are listed, not extracted.

Back to Aveanna Healthcare Holdings Inc.